Source: Annual Congress 2009 - Pathogenesis of pulmonary fibrosis
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Kaga, F. Sakai, Y. Usui, K. Kobayashi, M. Nagata, K. Hagiwara, M. Kanazawa (Saiatama, Saitama, Japan). Clinicoradiological features of chronic fibrosing interstitial pneumonia with smoking history. Eur Respir J 2009; 34: Suppl. 53, 242

Member's Comments

No comment yet.

Related content which might interest you: The natural history of progressive fibrosing interstitial lung diseases Source: Eur Respir J, 55 (6) 2000085; 10.1183/13993003.00085-2020 Year: 2020 Incidence and prevalence of idiopathic pulmonary fibrosis: review of the literature Source: Eur Respir Rev 2012 21: 355-361 Year: 2012 Clinical features of pulmonary aspergillosis in patients with chronic fibrosing interstitial pneumonia Source: Annual Congress 2010 - Different patterns of diffuse parenchymal lung disease Year: 2010 Cryptogenic fibrosing alveolitis/idiopathic pulmonary fibrosis Source: Eur Respir J 2001; 18: 43S-55S Year: 2001 The classification, natural history and radiological/histological appearance of idiopathic pulmonary fibrosis and the other idiopathic interstitial pneumonias Source: Eur Respir Rev 2008; 17: 108-115 Year: 2008 Fibrosing cases of chronic eosinophilic pneumonia Source: Virtual Congress 2020 – Clinical aspects and new treatment strategies for rare interstitial lung diseases in adults and children Year: 2020 Clinical course and outcomes of acute exacerbation of fibrosing interstitial lung disease Source: Virtual Congress 2021 – Prognostic markers of disease progression in non-idiopathic pulmonary fibrosis interstitial lung diseases Year: 2021 Comment on “The natural history of progressive fibrosing interstitial lung diseases” Source: Eur Respir J, 56 (6) 2003508; 10.1183/13993003.03508-2020 Year: 2020 Prevalence of progressive fibrosing interstitial lung disease Source: International Congress 2018 – Pitfalls in the diagnosis and management of rare diffuse parenchymal lung diseases (DPLDs) Year: 2018 Chronic hypersensitivity pneumonitis with familial history of interstitial lung disease Source: Annual Congress 2010 - Pathogenesis of diffuse parenchymal lung disease Year: 2010 The features of the course of cryptogenic fibrosing alveolitis in women Source: Eur Respir J 2002; 20: Suppl. 38, 59s Year: 2002 Idiopathic chronic eosinophilic pneumonia and asthma: how do they influence each other? Source: Eur Respir J 2003; 22: 8-13 Year: 2003 Survival after respiratory hospitalization in patients with idiopathic chronic fibrosing interstitial pneumonia Source: International Congress 2018 – What is new in idiopathic interstitial pneumonias? Year: 2018 Specific features of the course of cryptogenic fibrosing alveolitis in pregnancy Source: Eur Respir J 2001; 18: Suppl. 33, 150s Year: 2001 Different characteristics and outcomes of acute exacerbation: comparison between interstitial pneumonia with autoimmune features and lone idiopathic interstitial pneumonia. Source: International Congress 2018 – Consequences of idiopathic interstitial pneumonias Year: 2018 An integrated approach in the diagnosis of smoking-related interstitial lung diseases Source: Eur Respir Rev 2012 21:207-217 Year: 2012 Clinical significance of histological classification of idiopathic interstitial pneumonia Source: Eur Respir J 2002; 19: 275-283 Year: 2002 Bronchiolitis as a component in idiopathic pulmonary fibrosis and idiopathic interstitial pneumonias: clinico-pathological characteristics Source: Eur Respir J 2004; 24: Suppl. 48, 534s Year: 2004 The influence of smoking history on the prognosis of idiopathic pulmonary fibrosis Source: Annual Congress 2010 - Clinical aspects in pulmonary fibrosis Year: 2010 Manifestation of idiopathic chronic eosinophilic pneumonia Source: Annual Congress 2009 - Clinical aspects of diffuse parenchymal lung disease Year: 2009